Di-Methyl-Histone H1 (Lys25) Antibody

What is Di-Methyl-Histone H1 (Lys25) Antibody and what are its key specifications?

Di-Methyl-Histone H1 (Lys25) Antibody is a rabbit polyclonal antibody specifically designed to detect endogenous histone H1 proteins that have been di-methylated at the lysine 25 position. This antibody is typically affinity-purified using the immunogen and demonstrates reactivity with human, mouse, and rat species . It is generally supplied at a concentration of 1.0mg/ml in a formulation containing PBS (pH 7.4), 0.02% sodium azide as a preservative, and 50% glycerol . The molecular weight of the target protein typically appears between 17-25 kDa in SDS-PAGE analysis . It's important to note that this antibody has been validated for Western blotting applications, with recommended dilutions ranging from 1:500-1:1000 .

The antibody recognizes histone H1 that has undergone a specific post-translational modification (di-methylation at lysine 25), which is crucial for researchers investigating epigenetic regulation and chromatin structure dynamics . For optimal results and long-term stability, the antibody should be stored at -20°C .

How should researchers validate the specificity of Di-Methyl-Histone H1 (Lys25) Antibody in their experimental systems?

Validating antibody specificity is critical for generating reliable data in histone modification research. For Di-Methyl-Histone H1 (Lys25) Antibody, a multi-faceted approach is recommended:

Peptide Competition Assay

Perform Western blot analysis with the antibody pre-incubated with its specific immunogen (the synthetic di-methylated peptide corresponding to residues surrounding Lys25 of human histone H1) . Signal reduction or elimination confirms specificity.

Positive and Negative Controls

Include samples with known expression levels of di-methylated H1K25. The antibody has been shown to work effectively with HeLa and 3T3 cell lines, which can serve as positive controls . Consider using samples from knockdown experiments or cell types with minimal H1 expression as negative controls.

Cross-Reactivity Assessment

Test the antibody against samples containing other histone methylation marks to ensure it doesn't cross-react with similar modifications. Since this antibody was generated using a synthetic di-methylated peptide corresponding specifically to residues surrounding Lys25, it should demonstrate high specificity .

Multiple Detection Methods

Validate findings using complementary techniques beyond Western blotting, such as immunofluorescence or chromatin immunoprecipitation, depending on the research question.

The specificity of this antibody has been demonstrated through Western blot analysis of HeLa and 3T3 cell lysates, as evidenced by clear, specific bands at the expected molecular weight range of 17-25 kDa .

What is the optimal protocol for Western blotting with Di-Methyl-Histone H1 (Lys25) Antibody?

For optimal Western blotting results with Di-Methyl-Histone H1 (Lys25) Antibody:

Histone Extraction Protocol

• Lyse cells with 5% perchloric acid for 1 hour at 4°C to effectively extract histones

• Precipitate soluble acid proteins with 30% trichloroacetic acid overnight at 4°C

• Wash the precipitate twice with 0.5 ml of acetone

• Reconstitute in water

• Determine protein concentration using a sensitive assay such as Micro BCA

Western Blotting Procedure

• Separate purified histones using 10% SDS-PAGE

• Transfer proteins to a PVDF membrane

• Block with a suitable blocking buffer (such as Odyssey blocking buffer) for 1 hour

• Incubate with Di-Methyl-Histone H1 (Lys25) Antibody at a dilution of 1:500-1:1000 overnight at 4°C

• Wash membrane thoroughly with PBST

• Incubate with an appropriate secondary antibody (such as IRDye 680 goat anti-rabbit IgG) for 1 hour at room temperature

• Visualize using a suitable detection system

Critical Parameters:

• Ensure complete histone extraction using acid precipitation methods

• Maintain antibody dilution between 1:500-1:1000 for optimal signal-to-noise ratio

• For secondary antibody, a dilution of 1:20000 has been validated in previous studies

• Include appropriate loading controls for histones (such as total H3 or H4)

This protocol has been validated on human, mouse, and rat samples, making it versatile for cross-species studies .

How do histone H1 variants expression patterns differ between pluripotent and differentiated cells?

Research on histone H1 variants has revealed striking differences in expression patterns between pluripotent cells (PCs) and differentiated cells, which has significant implications for chromatin organization and gene regulation:

Expression Pattern Comparison

Pluripotent cells display a more diverse repertoire of histone H1 variants, with higher levels of H1.1, H1.3, and H1.5 compared to differentiated cells . In contrast, differentiated cells predominantly express H1.0, which can represent up to 80% of the total H1 content in adult somatic cells like keratinocytes .

This differential expression is regulated at the transcriptional level. The regulatory regions of H1.3 and H1.5 genes are occupied by pluripotency factors in stem cells, explaining their elevated expression in pluripotent cells. Meanwhile, the H1.0 gene promoter contains bivalent domains (H3K4me2 and H3K27me3) in pluripotent cells, suggesting it is poised for activation during differentiation .

These expression patterns are reciprocal during cellular transitions: during differentiation of embryonic stem cells, H1.0 expression increases significantly, while H1.1, H1.3, and H1.5 decrease. Conversely, during reprogramming of keratinocytes to induced pluripotent stem cells, H1.0 decreases while H1.1, H1.3, and H1.5 increase .

What methodological approaches can be used to investigate the functional consequences of Histone H1 lysine 25 di-methylation?

To investigate the functional consequences of Histone H1 lysine 25 di-methylation, researchers can employ several complementary approaches:

Chromatin Immunoprecipitation (ChIP) Analysis

• Use Di-Methyl-Histone H1 (Lys25) Antibody to immunoprecipitate chromatin fragments

• Couple with high-throughput sequencing (ChIP-seq) to map genomic locations where this modification occurs

• Compare these locations with gene expression data to identify correlations with transcriptional activity

• Analyze enrichment at specific genomic features (promoters, enhancers, etc.)

Functional Knockdown/Knockout Studies

Similar to approaches used for H1.0 studies in ES cells, researchers can:

• Design knockdown experiments targeting specific methyltransferases responsible for H1K25 di-methylation

• Assess the impact on self-renewal and differentiation capacities of stem cells

• Evaluate changes in chromatin compaction and accessibility using techniques like ATAC-seq

Mass Spectrometry Analysis

• Employ histone acid extraction protocols to isolate histones

• Use mass spectrometry to quantify levels of H1K25 di-methylation across different cell types or conditions

• Identify co-occurring histone modifications that may function together with H1K25me2

Immunofluorescence Microscopy

• Use Di-Methyl-Histone H1 (Lys25) Antibody for immunofluorescence to examine nuclear distribution

• Combine with markers of various chromatin states (heterochromatin vs. euchromatin)

• Analyze changes during cellular processes like differentiation or cell cycle

Previous research has demonstrated that H1 variants have different functional roles. For example, knockdown of H1.0 did not affect self-renewal of human ES cells but impaired their differentiation capacity . Similar approaches could be applied to investigate the specific role of H1K25 di-methylation in chromatin dynamics and cellular processes.

How can researchers optimize sample preparation for histone modification analysis?

Optimal sample preparation is crucial for accurate histone modification analysis, particularly when studying di-methylated histone H1 at lysine 25:

Acid Extraction Protocol for Histones

• Harvest cells at 70-80% confluence for consistency

• Lyse cells with 5% perchloric acid for 1 hour at 4°C to selectively extract histones

• Precipitate acid-soluble proteins with 30% trichloroacetic acid (TCA) overnight at 4°C

• Wash precipitate twice with 0.5 ml of acetone to remove acid residues

• Air dry briefly and reconstitute in water or appropriate buffer

• Determine protein concentration using Micro BCA protein assay or similar sensitive method

Critical Considerations for Sample Preparation:

• Protease Inhibitors: Always include a complete protease inhibitor cocktail to prevent degradation

• Phosphatase Inhibitors: Include phosphatase inhibitors (sodium fluoride, sodium orthovanadate) to prevent loss of phosphorylation marks

• Deacetylase Inhibitors: Add histone deacetylase inhibitors (sodium butyrate, trichostatin A) to preserve acetylation marks

• Cell Density Control: Standardize cell density across samples, as histone modifications can vary with cell confluence

• Rapid Processing: Minimize processing time to prevent degradation or artificial modification changes

• Temperature Control: Maintain samples at 4°C throughout extraction to preserve labile modifications

Sample Storage:

• Store extracted histones at -80°C for long-term storage

• Avoid repeated freeze-thaw cycles which can degrade proteins and affect modifications

• For Di-Methyl-Histone H1 (Lys25) Antibody itself, store at -20°C as recommended

This optimized extraction method ensures preservation of histone modifications and has been validated in studies of histone variant expression during cellular differentiation .

What are the best troubleshooting strategies for non-specific binding when using Di-Methyl-Histone H1 (Lys25) Antibody?

When encountering non-specific binding issues with Di-Methyl-Histone H1 (Lys25) Antibody, researchers should implement the following troubleshooting strategies:

Optimizing Antibody Concentration

• Perform a titration series using dilutions ranging from 1:250 to 1:2000

• The recommended dilution range of 1:500-1:1000 for Western blotting should be fine-tuned for each specific laboratory setup

• For HeLa and 3T3 cell lines, a 1:2000 dilution has been successfully used with appropriate secondary antibody dilution (1:20000)

Blocking Optimization

• Test alternative blocking agents beyond standard BSA or milk:

  • For histone antibodies, 5% BSA in TBST often provides superior results

  • Commercial blockers like Odyssey blocking buffer have shown effectiveness

• Extend blocking time to 2 hours at room temperature or overnight at 4°C

• Include 0.1-0.3% Tween-20 in blocking and antibody dilution buffers

Cross-Adsorption Strategy

If cross-reactivity with other histone modifications is suspected:

• Pre-incubate the antibody with non-specific histone peptides lacking the K25me2 modification

• Use peptide competition assays with the specific immunogen peptide as a control

• The antibody is generated using a synthetic di-methylated peptide corresponding specifically to residues surrounding Lys25, which should provide high specificity

Sample Preparation Refinement

• Ensure complete histone extraction using the acid extraction method (5% perchloric acid)

• Increase washing stringency during protein extraction

• Consider enriching for histone H1 fraction before analysis

Additional Controls

• Include samples from tissues known to be negative for H1K25 di-methylation

• Use secondary antibody-only controls to identify background from the detection system

• Consider including samples treated with demethylase enzymes as negative controls

These troubleshooting approaches will help ensure specific detection of di-methylated Histone H1 at lysine 25, minimizing artifacts that could confound experimental interpretation.

How can Di-Methyl-Histone H1 (Lys25) Antibody be integrated into multi-parameter epigenetic studies?

Integrating Di-Methyl-Histone H1 (Lys25) Antibody into multi-parameter epigenetic studies requires thoughtful experimental design to maximize information yield:

Sequential Chromatin Immunoprecipitation (Re-ChIP)

• Perform initial ChIP with Di-Methyl-Histone H1 (Lys25) Antibody

• Re-immunoprecipitate the eluted material with antibodies against other chromatin marks

• This reveals genomic regions where H1K25me2 co-occurs with other modifications

• Particularly valuable for examining relationships with bivalent domains (H3K4me2/H3K27me3) identified in pluripotent cells

Multiplexed Western Blotting

• Use fluorescently-labeled secondary antibodies with distinct emission spectra

• Simultaneously probe for H1K25me2 and other histone marks on the same membrane

• The antibody has been validated with fluorescent secondary antibodies (IRDye systems)

• This approach allows direct comparison of different modifications across samples

Correlation with Chromatin States

• Combine Di-Methyl-Histone H1 (Lys25) Antibody detection with global assays of chromatin accessibility (ATAC-seq, DNase-seq)

• Map H1K25me2 distribution in relation to euchromatic and heterochromatic regions

• Examine correlations with other repressive marks in differentiated vs. pluripotent cells, given the dynamic expression of H1 variants during differentiation

Integration with Transcriptomic Data

• Correlate H1K25me2 levels with gene expression profiles from RNA-seq

• Focus particularly on genes regulated during differentiation processes

• Research has shown that H1 variants play critical roles in differentiation, suggesting H1K25me2 may have functional importance in this context

This integrated approach allows researchers to place H1K25 di-methylation within the broader context of epigenetic regulation, particularly in processes like stem cell differentiation where histone H1 variants show distinctive expression patterns .

What are the differences in expression and function between histone H1 variants in cellular differentiation?

Histone H1 variants exhibit distinct expression patterns and functional roles during cellular differentiation, providing important context for studying specific modifications like di-methylation at lysine 25:

Expression Dynamics During Differentiation and Reprogramming

Research on human embryonic stem (ES) cells, teratocarcinoma cells, and induced pluripotent stem (iPS) cells has revealed specific patterns:

Functional Insights from Knockdown Studies

Experimental knockdown of H1.0 in human ES cells did not affect self-renewal capabilities but significantly impaired differentiation capacity . This suggests that specific H1 variants play critical roles in facilitating cellular transition states.

Regulatory Mechanisms

The differential expression of H1 variants is controlled at the transcriptional level:

• H1.3 and H1.5 gene promoters are occupied by pluripotency transcription factors in ES cells

• H1.0 gene contains bivalent domains (H3K4me2 and H3K27me3) in pluripotent cells, poising it for activation during differentiation

Repertoire Diversity

Pluripotent cells maintain a more diverse repertoire of H1 variants, while differentiated cells predominantly express H1.0 (up to 80% of total H1 in keratinocytes) . This suggests that the complexity of H1 variant composition may be important for maintaining pluripotency.

These expression patterns provide critical context for studying specific histone H1 post-translational modifications like di-methylation at lysine 25, as the functional significance of such modifications may vary depending on which H1 variant they occur on and the cellular differentiation state.

Histone H1's Role in Chromatin Organization

Histone H1 serves as a linker histone that interacts with DNA between nucleosomes and facilitates the compaction of chromatin into higher order structures . Post-translational modifications of H1, including methylation at specific lysine residues like K25, likely modulate these interactions and influence chromatin accessibility.

Relationship to Cell State and Differentiation

Given the dramatic changes in H1 variant expression during differentiation, with pluripotent cells exhibiting a more diverse H1 repertoire than differentiated cells , specific modifications like di-methylation at K25 may play distinct roles in different cellular contexts. The timing and distribution of this modification might correlate with the expression patterns of specific H1 variants.

Potential Mechanism in Gene Regulation

Histone modifications serve as binding platforms for specific protein complexes. Di-methylation of H1K25 likely creates a recognition site for specific reader proteins that might recruit additional factors to modulate chromatin structure or transcriptional activity. The modification could function in:

• Transcriptional repression through recruitment of silencing complexes

• Chromatin compaction by altering H1-DNA interaction strength

• Cell-type specific gene regulation during development and differentiation

• Cross-talk with core histone modifications like those found in bivalent domains (H3K4me2/H3K27me3)

Technical Approaches for Further Study

Researchers interested in advancing understanding of H1K25me2 should consider:

• ChIP-seq studies using the Di-Methyl-Histone H1 (Lys25) Antibody to map genomic distribution

• Mass spectrometry to quantify this modification across different H1 variants

• Identification of writer enzymes (methyltransferases) responsible for adding this mark

• Identification of reader proteins that specifically recognize this modification

• Correlation studies with gene expression and chromatin accessibility datasets

While the specific function of H1K25 di-methylation awaits further characterization, its study should be considered within the broader context of histone H1 variant dynamics during processes like differentiation, where dramatic shifts in H1 composition have been documented .

How can researchers quantitatively analyze changes in histone H1 modifications during cellular processes?

Quantitative analysis of histone H1 modifications, including di-methylation at lysine 25, requires robust methodological approaches:

Western Blot Quantification

• Extract histones using the perchloric acid method (5% perchloric acid lysis for 1h at 4°C)

• Separate using 10% SDS-PAGE and transfer to PVDF membrane

• Probe with Di-Methyl-Histone H1 (Lys25) Antibody at 1:500-1:1000 dilution

• Visualize using fluorescently-labeled secondary antibodies (e.g., IRDye 680 goat anti-rabbit IgG)

• Quantify signal intensity using systems like the Odyssey Infrared Imaging System

• Normalize to total H1 levels or other suitable loading controls

• Calculate relative changes across experimental conditions

Quantitative Mass Spectrometry

• Isolate histones using acid extraction

• Perform propionylation of unmodified and monomethylated lysines (to prevent trypsin digestion at these sites)

• Digest with trypsin to generate peptides containing the K25 residue

• Analyze using LC-MS/MS with multiple reaction monitoring (MRM)

• Quantify the relative abundance of different H1K25 modification states

• Compare across experimental conditions or time points during cellular processes

ChIP-qPCR for Locus-Specific Quantification

• Perform ChIP using Di-Methyl-Histone H1 (Lys25) Antibody

• Design primers targeting specific genomic regions of interest

• Conduct qPCR to measure enrichment of H1K25me2 at these loci

• Calculate percent input or fold enrichment compared to IgG control

• Compare enrichment across different cell states or treatments

RT-qPCR for H1 Variant Expression Analysis

To contextualize modification data, quantify expression of H1 variants:

• Extract RNA and synthesize cDNA

• Design specific primers for each H1 variant

• Perform qPCR with normalization to GAPDH

• Calculate relative expression using the ΔΔCt method

• Adjust expression data by normalization to genomic DNA amplification

This approach has successfully demonstrated that pluripotent cells express a different repertoire of H1 variants compared to differentiated cells, with H1.0 increasing from <20% to 40-45% of total H1 during differentiation .

Temporal Analysis Framework

For studying dynamics during processes like differentiation:

• Collect samples at multiple time points (e.g., days 0, 5, 10, 15, 20 of differentiation)

• Perform parallel analysis of:

  • H1 variant expression by RT-qPCR

  • H1K25me2 levels by Western blot

  • Genomic distribution by ChIP-seq

• Correlate changes with expression of lineage markers and pluripotency factors

This comprehensive approach allows researchers to track both the expression of H1 variants and their post-translational modifications during dynamic cellular processes.

What are the technical considerations for designing ChIP experiments with Di-Methyl-Histone H1 (Lys25) Antibody?

Designing effective Chromatin Immunoprecipitation (ChIP) experiments with Di-Methyl-Histone H1 (Lys25) Antibody requires careful consideration of several technical factors specific to linker histones:

Chromatin Preparation Considerations

• Crosslinking Optimization: Standard 1% formaldehyde for 10 minutes may be insufficient for capturing linker histone interactions

  • Consider dual crosslinking with both formaldehyde and protein-protein crosslinkers like DSG or EGS

  • Test crosslinking times between 5-20 minutes to optimize capture of H1-DNA interactions

• Sonication Parameters:

  • Aim for slightly larger fragments (300-700 bp) than typical histone ChIP (200-300 bp)

  • This helps preserve the linker histone-DNA interactions which occur between nucleosomes

  • Monitor sonication efficiency by agarose gel electrophoresis

• Salt Concentration Adjustments:

  • H1 histones bind DNA with lower affinity than core histones

  • Consider reducing salt concentration in wash buffers to 100-150 mM NaCl

Antibody Usage Optimization

• Antibody Amount:

  • For Di-Methyl-Histone H1 (Lys25) Antibody, start with 2-5 μg per ChIP reaction

  • Perform titration experiments to determine optimal antibody:chromatin ratio

• Pre-clearing Strategy:

  • Implement rigorous pre-clearing of chromatin with protein A/G beads

  • Include non-specific IgG to reduce background binding

• Incubation Time:

  • Extend antibody-chromatin incubation to overnight at 4°C

  • Consider gentle rotation rather than strong agitation to preserve interactions

Controls and Validation

• Essential Controls:

  • Input chromatin (pre-immunoprecipitation material)

  • Non-specific IgG from same species (rabbit)

  • Positive control regions (genes known to be regulated by histone H1)

  • Negative control regions (genes unlikely to be regulated by histone H1)

• Validation Approaches:

  • Perform parallel ChIP with antibodies against total histone H1

  • Compare enrichment patterns with core histone marks like H3K27me3 (repressive) or H3K4me3 (active)

  • Consider sequential ChIP (Re-ChIP) to identify co-occupancy with other marks

Analysis Considerations

• Peak Calling Parameters:

  • H1 typically shows broader distribution patterns than punctate transcription factor binding

  • Use peak calling algorithms suitable for histone modifications (e.g., SICER or RSEG)

  • Consider broader peak width parameters than standard settings

• Data Integration:

  • Compare H1K25me2 distribution with:

    • Expression patterns of different H1 variants

    • Core histone modifications

    • Gene expression data from similar cellular states